Dextroamphetamine
- Generic Name
- Dextroamphetamine
- Brand Names
- Adderall, Dexedrine, Mydayis, Procentra, Xelstrym, Zenzedi
- Drug Type
- Small Molecule
- Chemical Formula
- C9H13N
- CAS Number
- 51-64-9
- Unique Ingredient Identifier
- TZ47U051FI
- Background
Dextroamphetamine is the dextrorotary enantiomer of amphetamine. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder.
- Indication
Dextroamphetamine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).
- Associated Conditions
- Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy
- Associated Therapies
- -
A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence
- Conditions
- Interventions
- First Posted Date
- 2008-03-07
- Last Posted Date
- 2013-06-03
- Target Recruit Count
- 60
- Registration Number
- NCT00630682
- Locations
- 🇺🇸
CPMC-St. Luke's Campus-Addiction Pharmacology Research Laboratory, San Francisco, California, United States
Substance Abuse Pre-Treatment Screening Study
- First Posted Date
- 2007-02-22
- Last Posted Date
- 2023-12-20
- Target Recruit Count
- 7500
- Registration Number
- NCT00439049
- Locations
- 🇺🇸
University of Texas Medical School- Houston, Dept. of Psychiatry Mental Sciences Institute, Houston, Texas, United States
Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression
- Conditions
- Interventions
- First Posted Date
- 2006-02-27
- Last Posted Date
- 2012-04-27
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 31
- Registration Number
- NCT00296686
- Locations
- 🇺🇸
Depression Evaluation Service - New York State Psychiatric Institute, New York, New York, United States
Apathy Associated With Alzheimer's Disease
- Conditions
- First Posted Date
- 2005-11-15
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 40
- Registration Number
- NCT00254033
- Locations
- 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder
- Conditions
- First Posted Date
- 2005-09-28
- Last Posted Date
- 2013-10-31
- Lead Sponsor
- Stony Brook University
- Target Recruit Count
- 40
- Registration Number
- NCT00228046
- Locations
- 🇺🇸
Stony Brook University Hospital, Stony Brook, New York, United States
🇺🇸Long Island Jewish Medical Center / Schneider Children's Hospital, New Hyde Park, New York, United States
Amphetamine Cocaine Interaction Study - 2
- Conditions
- Locations
- 🇺🇸
University of Texas Health Science Center, Houston, Texas, United States
Dextroamphetamine-Cocaine Behavioral Intervention - 5
- Conditions
- Interventions
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 54
- Registration Number
- NCT00000308
- Locations
- 🇺🇸
University of Texas Health Science Center, Houston, Texas, United States
Dextroamphetamine as an Adjunct in Cocaine Treatment - 1
- Conditions
- Interventions
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 120
- Registration Number
- NCT00000304
- Locations
- 🇺🇸
University of Texas Health Science Center, Houston, Texas, United States
Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
- Conditions
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 140
- Registration Number
- NCT00000306
- Locations
- 🇺🇸
University of Texas Health Science Center, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.